184 related articles for article (PubMed ID: 27281077)
21. Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: A prospective observational study.
Mavropoulou E; Mechie NC; Knoop R; Petzold G; Ellenrieder V; Kunsch S; Pilavakis Y; Amanzada A
PLoS One; 2020; 15(5):e0233811. PubMed ID: 32470973
[TBL] [Abstract][Full Text] [Related]
22. Relationship between serum interleukin-17 level and inflammatory bowel disease.
Liu QL; Huang L; Zhao QJ; Li Q; He Z
J Biol Regul Homeost Agents; 2016; 30(1):181-8. PubMed ID: 27049090
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-18 serum levels in inflammatory bowel diseases: correlation with disease activity and inflammatory markers.
Haas SL; Abbatista M; Brade J; Singer MV; Böcker U
Swiss Med Wkly; 2009 Mar; 139(9-10):140-5. PubMed ID: 19274491
[TBL] [Abstract][Full Text] [Related]
24. Anti-alpha-enolase antibody as a serologic marker and its correlation with disease severity in intestinal Behçet's disease.
Shin SJ; Kim BC; Kim TI; Lee SK; Lee KH; Kim WH
Dig Dis Sci; 2011 Mar; 56(3):812-8. PubMed ID: 20632102
[TBL] [Abstract][Full Text] [Related]
25. [Could the cytokines concentration be a marker of IBD activity and be useful in evaluation of IBD differentiation?].
Cieċko-Michalska I; Wierzbicka-Tutka I; Szczepanek M; Fedak D; Mach T
Przegl Lek; 2016; 73(5):301-4. PubMed ID: 29629745
[TBL] [Abstract][Full Text] [Related]
26. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases.
Schönauen K; Le N; von Arnim U; Schulz C; Malfertheiner P; Link A
Inflamm Bowel Dis; 2018 Jun; 24(7):1547-1557. PubMed ID: 29668922
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic features and genetic background of inflammatory bowel disease complicated with Takayasu arteritis.
Akiyama S; Fujii T; Matsuoka K; Yusuke E; Negi M; Takenaka K; Nagahori M; Ohtsuka K; Isobe M; Watanabe M
J Gastroenterol Hepatol; 2017 May; 32(5):1011-1017. PubMed ID: 28449344
[TBL] [Abstract][Full Text] [Related]
28. Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease.
Farias E Silva K; Nanini HF; Cascabulho CM; Rosas SLB; Santana PT; Carneiro AJV; Anaissie E; Nucci M; de Souza HSP
World J Gastroenterol; 2021 Mar; 27(9):866-885. PubMed ID: 33727775
[TBL] [Abstract][Full Text] [Related]
29. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
Zhang W; Teng G; Wu T; Tian Y; Wang H
Inflamm Bowel Dis; 2017 Dec; 23(12):2134-2141. PubMed ID: 29084078
[TBL] [Abstract][Full Text] [Related]
30. Decreased serum fetuin-A levels and active inflammatory bowel disease.
Ma P; Feng YC
Am J Med Sci; 2014 Jul; 348(1):47-51. PubMed ID: 24487480
[TBL] [Abstract][Full Text] [Related]
31. Development and Validation of an Inflammatory Bowel Diseases Monitoring Index for Use With Mobile Health Technologies.
Van Deen WK; van der Meulen-de Jong AE; Parekh NK; Kane E; Zand A; DiNicola CA; Hall L; Inserra EK; Choi JM; Ha CY; Esrailian E; van Oijen MG; Hommes DW
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1742-1750.e7. PubMed ID: 26598228
[TBL] [Abstract][Full Text] [Related]
32. Serum interleukin-18 concentrations in patients with inflammatory bowel disease.
Furuya D; Yagihashi A; Komatsu M; Masashi N; Tsuji N; Kobayashi D; Watanabe N
J Immunother; 2002; 25 Suppl 1():S65-7. PubMed ID: 12048353
[TBL] [Abstract][Full Text] [Related]
33. Intestinal interleukin-13 in pediatric inflammatory bowel disease patients.
Kadivar K; Ruchelli ED; Markowitz JE; Defelice ML; Strogatz ML; Kanzaria MM; Reddy KP; Baldassano RN; von Allmen D; Brown KA
Inflamm Bowel Dis; 2004 Sep; 10(5):593-8. PubMed ID: 15472520
[TBL] [Abstract][Full Text] [Related]
34. Results of multiple diagnostic tests for Mycobacterium avium subsp. paratuberculosis in patients with inflammatory bowel disease and in controls.
Collins MT; Lisby G; Moser C; Chicks D; Christensen S; Reichelderfer M; Høiby N; Harms BA; Thomsen OO; Skibsted U; Binder V
J Clin Microbiol; 2000 Dec; 38(12):4373-81. PubMed ID: 11101567
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-12B gene rs6887695 and rs2288831 polymorphisms are associated with an increased risk of ulcerative colitis development in Chinese Han population: A case-control study.
Zhao H; Qian YZ; Qian HH
J Clin Lab Anal; 2020 Nov; 34(11):e23472. PubMed ID: 32666631
[TBL] [Abstract][Full Text] [Related]
36. [Significance of serum calprotectin in assessing inflammatory bowel disease activity].
Mao JY; Li L; Pang Z
Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(38):3001-3004. PubMed ID: 29061007
[No Abstract] [Full Text] [Related]
37. Serum biomarkers confirming stable remission in inflammatory bowel disease.
Kessel C; Lavric M; Weinhage T; Brueckner M; de Roock S; Däbritz J; Weber J; Vastert SJ; Foell D
Sci Rep; 2021 Mar; 11(1):6690. PubMed ID: 33758351
[TBL] [Abstract][Full Text] [Related]
38. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.
Zhang S; Luo J; Li J; Wu Z; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
Clin Chem Lab Med; 2017 May; 55(6):865-875. PubMed ID: 27831916
[TBL] [Abstract][Full Text] [Related]
39. Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis.
Schmidt C; Giese T; Ludwig B; Mueller-Molaian I; Marth T; Zeuzem S; Meuer SC; Stallmach A
Inflamm Bowel Dis; 2005 Jan; 11(1):16-23. PubMed ID: 15674109
[TBL] [Abstract][Full Text] [Related]
40. Neuroimmune interactions in patients with inflammatory bowel diseases: disease activity and clinical behavior based on Substance P serum levels.
Tavano F; di Mola FF; Latiano A; Palmieri O; Bossa F; Valvano MR; Latiano T; Annese V; Andriulli A; di Sebastiano P
J Crohns Colitis; 2012 Jun; 6(5):563-70. PubMed ID: 22398048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
